Interpretation of Pharmacological Treatment and Comprehensive Management of Atrial Fibrillation in 2024 JCS/JHRS Updated Guideline for the Management of Cardiac Arrhythmias
10.3870/j.issn.1004-0781.2025.11.011
- VernacularTitle:在2024版《心律失常管理指南更新》中心房颤动的药物治疗与综合管理解读
- Author:
Jianting LIAO
1
;
Changli HE
1
;
Lizhu HAN
1
;
Qinan YIN
1
;
Yuan BIAN
1
;
Gang LI
1
;
Jinqi LI
1
Author Information
1. 四川省医学科学院·四川省人民医院药学部,成都 610072;电子科技大学医学院,个体化药物治疗四川省重点实验室,成都 610072
- Publication Type:Journal Article
- Keywords:
Updated Guidelines for the Management of Cardiac Arrhythmias;
Atrial fibrillation;
Anticoagulation therapy;
Direct oral anticoagulants;
HELT-E2 S2 Score;
Comprehensive management
- From:
Herald of Medicine
2025;44(11):1789-1793
- CountryChina
- Language:Chinese
-
Abstract:
In 2024,the Japanese Circulation Society(JCS)and the Japanese Heart Rhythm Society(JHRS)jointly released the updated guidelines for the management of cardiac arrhythmias.The guideline provided updates on strategies for arrhythmias management,including device therapy,catheter ablation,pharmacological treatment and comprehensive management of atrial fibrillation(AF).This article focuses on the management of AF,including stroke risk assessment,oral anticoagulation therapy,high-risk patients management,comprehensive strategies,and lifestyle interventions.The guideline proposed a new stroke risk scoring tool,the HELT-E2 S2 score,refined the management of anticoagulation therapy in special high-risk patients,and updated comprehensive management strategies and lifestyle interventions for AF.These updates aim to enhance the prognosis and quality of life for AF patients,and also provide valuable insights for the management optimization of AF patients in China.
